Two years after its launch, venture firm Seventure has closed its Health for Life Capital fund at $175m after Novartis joined a raft of existing corporate partners.
France-based venture capital firm Seventure Partners closed a €160m ($175m) health and nutrition fund on Monday that received funding from pharmaceutical firm Novartis.
Officially launched in December 2013, Health for Life Capital targets companies developing microbiome and nutrition technology. Companies it has so far backed include Enterome, LNC, Maat Pharma, Eligo Bioscience, Targedys and Micropharma.
Novartis joins a partner list already featuring food product supplier Danone, sugar and bioethanol producer Tereos, yeast manufacturer Lesaffre, cheese producer Bel, and prosthesis maker…
